Related Experiment Video
Updated: Feb 9, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
circSMAD2 inhibits the epithelial-mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
Xianwei Zhang1, Ping Luo1, Wei Jing1
1Department of Clinical Laboratory Medicine, Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Background:
Circular RNAs (circRNAs) are a class of widely distributed non-coding RNAs, which drew little attention for decades. Recent studies show that circRNAs are involved in cancer progression.
Methods:
The circSMAD2 expression in HCC and adjacent non-tumor tissues was measured by quantitative real-time polymerase chain reaction, and the biological function of circSMAD2 was explored by proliferation, apoptosis, migration, invasion, and Western blot assays. Next, the dual-luciferase reporter assay was performed to identify the target miRNA of circSMAD2. Finally, circSMAD2 and its target miRNA were co-transfected in HCC cells to investigate their relationship to HCC progression.
Results:
In this study, we found that circRNA SMAD2 (circSMAD2) expression was downregulated in hepatocellular carcinoma (HCC) tissues (P = 0.014) compared to the adjacent non-tumor tissues and markedly associated with the differentiation degree of the HCC tissues (P < 0.001). The in vitro experiments showed that overexpressed circSMAD2 inhibited the migration, invasion, and epithelial-mesenchymal transition (EMT) in HCC cells. Bioinformatics predicted that miR-629 is a potential target of circSMAD2, and the dual-luciferase reporter assay verified that miR-629 directly bound circSMAD2. In addition, we found that overexpression of circSMAD2 suppressed the expression of miR-629 in HCC cells, whereas knockdown of circSMAD2 upregulated the expression of miR-629. Furthermore, co-transfection of miR-629 mimics with circSMAD2 reversed the circSMAD2 effects of inhibiting the migration, invasion, and EMT of HCC cells.
Conclusion:
Altogether, our data support that circSMAD2 inhibits the migration, invasion, and EMT of HCC cells by targeting miR-629.
Insights
Circular RNA SMAD2 (circSMAD2) is downregulated in liver cancer and inhibits tumor cell migration and invasion. It achieves this by targeting microRNA-629 (miR-629), suppressing its expression and thus hindering cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Non-coding RNA Research
Background:
- Circular RNAs (circRNAs) are non-coding RNA molecules with emerging roles in biological processes.
- Recent research highlights the involvement of circRNAs in the progression of various cancers, including hepatocellular carcinoma (HCC).
Purpose of the Study:
- To investigate the expression and function of circRNA SMAD2 (circSMAD2) in hepatocellular carcinoma (HCC).
- To elucidate the underlying molecular mechanism of circSMAD2 in regulating HCC progression, specifically its interaction with microRNA-629 (miR-629).
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) to measure circSMAD2 expression in HCC and adjacent non-tumor tissues.
- In vitro assays (proliferation, apoptosis, migration, invasion, Western blot) to assess circSMAD2's biological function.
- Dual-luciferase reporter assay and co-transfection experiments to validate the interaction between circSMAD2 and miR-629 and their roles in HCC.
Main Results:
- circSMAD2 expression was significantly downregulated in HCC tissues and associated with HCC differentiation.
- Overexpression of circSMAD2 inhibited HCC cell migration, invasion, and epithelial-mesenchymal transition (EMT).
- circSMAD2 directly targets and suppresses miR-629 expression in HCC cells, and this interaction is crucial for circSMAD2's tumor-suppressive effects.
Conclusions:
- circSMAD2 acts as a tumor suppressor in HCC by inhibiting cell migration, invasion, and EMT.
- The mechanism involves the direct targeting of miR-629 by circSMAD2, leading to the suppression of miR-629 activity.
Related Concept Videos
Phase Transitions
Feedback Inhibition
Properties of Transition Metals
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation
Phase Transitions: Sublimation and Deposition

